[1]
N. Rajdan, B. Srivastava, G. S. Titiyal, Shujauddin, and S. Kapri, “Comparative study to evaluate efficacy and safety of topical alcaftadine 0.25% versus topical olopatadine 0.2% eye drops in patients with allergic conjunctivitis in a tertiary care teaching hospital, Haldwani”, Int J Basic Clin Pharmacol, vol. 14, no. 2, pp. 165–170, Jan. 2025.